Date: April 18, 2024
To: All Relevant NSRA Branches
From: Director of Field Operations
Subject: Alert on Emerging Superhuman Drugs “Jump” and “Fly”
1. Introduction:
This memo serves as an urgent all-points bulletin to inform all active field agents and relevant NSRA personnel of two new substances identified on the streets, colloquially known as “Jump” and “Fly.” These substances have been associated with temporary and semi-permanent superhuman abilities, respectively.
2. Substance Identification:
- Jump is identified as a small green capsule containing a powder that grants temporary superpowers for approximately three hours.
- Fly is an injectable substance of varying colors (but typically opaque and brightly colored), administered via syringe, reported to grant permanent superpowers. Powers granted by Fly appear to weaken over time, but further observation is required to determine if the superpowers are functionally permanent or if further injections are required.
3. Street Names:
In addition to “Jump” and “Fly,” these drugs have been reported under various alternative street names, including “Leapfrog” and “Greens” (Jump) and “Wings”, “Go Time”, and “The Ooze” (Fly).
4. Reported Effects:
- Jump: Users report a wide range of temporary superhuman abilities, from enhanced strength to heightened senses. Side effects include mild to severe disorientation and physiological stress post-usage. A wide range of superhuman abilities have been reported, and powers typically last approximately three hours. Taking multiple Jump pills ‘stacks’ powers in a predictable fashion.
- Fly: Fly appears to be an altered form of Jump, capable of granting the same abilities on a more permanent basis. Besides granting permanent abilities, users have exhibited significant medical complications, including but not limited to jaundice, anemia, and altered blood chemistry, particularly increased bilirubin levels and blood pH. Repeated dosages of Fly of the same ‘strain’ amplify existing powers, but mixing two different ‘strains’ of Fly results in dangerously unpredictable effects, typically in the form of spontaneous autodestructive secondary or tertiary powers unrelated to the injected powers. In addition, Fly appears to produce powerful psychoactive effects when first injected that last for 1-2 hours.
5. Hypotheses on Mechanism:
Several hypotheses have been proposed regarding the operation of these substances:
- A genetic modification approach, potentially altering DNA to unlock or insert superhuman abilities.
- A biochemical interaction hypothesis suggests these drugs might target specific neural or muscular pathways to enhance or grant abilities.
- An exotic matter theory, where the drugs contain unknown compounds that temporarily or permanently alter human physiology in ways that enable superpowers.
- A placebo, with the drug only distributed to individuals with activation potential. The drug’s possible purpose is to convince the body of near-death circumstances.
Further testing is required in order to determine the specific mechanism of action of these drugs.
6. Distribution and Origin:
The exact source of “Jump” and “Fly” remains unknown. Investigations into their distribution have indicated a rapid spread across the Northeast, particularly in Washington DC, Baltimore, Philadelphia, and New York City, as well as their suburbs, suggesting a well-organized network behind their dissemination.
7. Law Enforcement and Superhuman Response:
Field agents are instructed to prioritize the investigation of “Jump” and “Fly” distribution, with an emphasis on identifying the source and distribution network. Interactions with users should be approached with caution due to the unpredictable nature of the powers granted by these substances.
8. Medical Advisory:
NSRA medical teams are on high alert for individuals presenting symptoms related to “Jump” and “Fly” usage. Special attention should be paid to those with altered blood chemistry and signs of hemolysis or metabolic alkalosis.
9. Public Safety Concerns:
Given the potential for misuse and the severe health risks associated with “Fly,” public safety announcements may be considered to warn against the use of unidentified superhuman-enhancing substances.
10. Collaboration with Health Agencies:
The NSRA is coordinating with national health agencies to monitor and respond to the health impacts of these drugs, including potential long-term effects on users and the broader public health implications. Any reports of bright orange blood or blood stains that dry yellow should be reported to local NSRA offices.
11. Agent Safety:
Field agents are reminded to use extreme caution when encountering individuals suspected of using “Jump” or “Fly.” Non-lethal containment measures are advised until the full range of powers can be assessed. When possible, contact local RSEs for collaboration and containment options.
12. Reporting Protocol:
All encounters with “Jump” or “Fly,” including samples, usage instances, or distribution networks, must be reported immediately through secure channels. Your cooperation is essential in addressing this emerging threat to public safety and national security.
Conclusion:
The emergence of “Jump” and “Fly” represents a significant challenge to superhuman regulation and public safety. The NSRA is committed to swiftly addressing this threat through comprehensive investigation, collaboration, and enforcement strategies. Your diligence and professionalism in these efforts are crucial.
End of Memorandum
Chum 